Denise Barbut MBBS, M.D., MRCP
President, Chief Executive Officer, and Director,Sarentis Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 1 different organizations across 3 different industries.|
Dr. Denise Barbut, MBBS, MD, MRCP founded CoAxia, Inc. in 1999. Dr. Barbut founded BeneChill, Inc. in 2004 and served as its Chief Executive Officer. She is the founder of Embol-X, CoAxia, Ortaco, and is a leader in the fields of stroke and embolic protection during surgery. She served as Associate Professor of Neurology and Director of the Stroke Research Program at Cornell University Medical College and Attending physician at the New York Hospital. She served as an ...
70 East 77th StreetPhone: 212-861-6348
New York, New York 10021
Board Members Memberships*
President, Chief Executive Officer, and Director
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.